1.8484
-0.0016
(-0.09%)
At close: January 24 at 4:00:00 PM EST
1.7800
-0.08
(-4.30%)
Pre-Market: 4:04:34 AM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 28.88M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.10 - 0.14 per share. | Indirect | 5,188,673 | Nov 19, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.23 per share. | Indirect | 164,730 | Jun 10, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.15 - 3.43 per share. | Indirect | 1,422,896 | Jun 9, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.99 - 3.03 per share. | Indirect | 1,288,962 | Jun 4, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.75 - 3.88 per share. | Indirect | 587,750 | May 2, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.54 - 3.74 per share. | Indirect | 1,291,607 | Apr 30, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.56 - 3.58 per share. | Indirect | 357,590 | Apr 10, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.16 per share. | Indirect | 951,912 | Apr 1, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.90 per share. | Indirect | 72,460 | Mar 28, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.15 - 3.38 per share. | Indirect | 8,795,089 | Mar 13, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.65 - 3.86 per share. | Indirect | 7,785,976 | Mar 7, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.94 - 3.99 per share. | Indirect | 3,880,899 | Mar 5, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.01 per share. | Indirect | 441,397 | Feb 27, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.91 - 3.95 per share. | Indirect | 1,811,921 | Feb 26, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.86 - 3.95 per share. | Indirect | 8,015,605 | Feb 25, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.84 per share. | Indirect | 3,840 | Feb 20, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.81 per share. | Indirect | 22,849 | Feb 13, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.40 - 3.71 per share. | Indirect | 1,339,890 | Feb 7, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.75 - 3.88 per share. | Indirect | 3,626,498 | Feb 5, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.43 - 3.69 per share. | Indirect | 5,678,874 | Feb 1, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.23 per share. | Indirect | 807,600 | Jan 30, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.21 - 3.23 per share. | Indirect | 2,508,660 | Jan 29, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.24 per share. | Indirect | 647,600 | Jan 25, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.88 - 2.99 per share. | Indirect | 1,875,164 | Jan 24, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.90 - 3.16 per share. | Indirect | 2,182,423 | Jan 22, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.06 - 3.16 per share. | Indirect | 4,379,160 | Jan 16, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.39 - 3.41 per share. | Indirect | 2,863,330 | Jan 14, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.87 - 3.30 per share. | Indirect | 13,818,234 | Jan 10, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.10 - 3.15 per share. | Indirect | 1,404,780 | Jan 4, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.89 per share. | Indirect | 3,757,000 | Jan 2, 2008 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.69 - 2.74 per share. | Indirect | 5,299,585 | Dec 31, 2007 |
| EDELMAN JOSEPH E Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.60 per share. | Indirect | 778,620 | Dec 27, 2007 |
| BENTSUR RON Chief Executive Officer | Purchase at price 1.30 per share. | Direct | 19,863 | Aug 21, 2007 |
| BENTSUR RON Chief Executive Officer | Purchase at price 2.98 per share. | Direct | 4,768 | Aug 25, 2006 |
Related Tickers
CANF Can-Fite BioPharma Ltd.
1.5600
+1.96%
PLUR Pluri Inc.
4.4500
-1.11%
PPBT Purple Biotech Ltd
3.6600
+1.67%
EVGN Evogene Ltd.
1.6600
-0.60%
MTLF.TA Matricelf Ltd
348.70
-1.94%
ENTX Entera Bio Ltd.
2.4000
-1.23%
AKTX Akari Therapeutics, Plc
1.1577
-2.71%
NRSNW NeuroSense Therapeutics Ltd.
0.3400
0.00%
NVCT Nuvectis Pharma, Inc.
6.55
+2.02%
ORMP Oramed Pharmaceuticals Inc.
2.2700
-1.30%